Siena Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.27M Sell
7,017
-321
-4% -$102K 1.48% 24
2022
Q2
$2.38M Sell
7,338
-361
-5% -$108K 1.44% 24
2022
Q1
$2.21M Sell
7,699
-2,220
-22% -$571K 1.25% 29
2021
Q4
$2.74M Buy
+9,919
New +$2.51M 1.57% 17

Other funds holding LLY

Siena Capital's LLY Position: Q3 2022 in Review

Siena Capital reduced its Eli Lilly (LLY) stake by 4.4% in Q3 2022, selling an estimated $102K and leaving 7,017 shares worth $2.27M. The position accounts for 1.48% of the portfolio, ranked #24.

Siena Capital first reported a position in LLY in Q4 2021 and has held it in 4 quarters since. The position peaked at $2.74M in Q4 2021. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.

  • Siena Capital held 7,017 shares of Eli Lilly worth $2.27M as of Q3 2022.
  • Siena Capital sold 321 Eli Lilly shares in Q3 2022, an estimated $102K.
  • Eli Lilly made up 1.48% of Siena Capital's portfolio in Q3 2022, its #24 holding.
  • Siena Capital first reported a position in Eli Lilly in Q4 2021 and has held it in 4 quarters since.
  • Siena Capital's Eli Lilly position peaked at $2.74M in Q4 2021.
  • 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.

Based on Siena Capital's 13F filing for Q3 2022, filed 2 Nov 2022.